Digital Edition: ‘Revolutionary’ Parkinson’s disease drugs trial starts at UK sites
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has begun at sites across the UK, according to researchers behind the initiative.
Welcome! To continue reading either:
Access your account
Log in to your account to access your content on Nursing Times.
Get unlimited access
Subscribe today to access over 6,000 peer-reviewed clinical articles, exclusive learning units, step-by-step procedures, the AI-powered Ask Nursing Times tool, the latest news, expert analysis, and the full NT Archive dating back to 1905.
Premium subscribers also get exclusive access to Nursing Insights – interactive dashboards covering workforce, patient experience, and public health. Benchmark performance, track trends, and make data-driven decisions to improve care and staff wellbeing. Nursing Insights can be purchased separately.
Register for free
Check if you already have access from your company or university
